What if one blood test could detect hundreds or even thousands of diseases?
Guardant Health CEO Helmy Eltoukhy joins South Park Commons Partner Mark Jacobstein to explain how that vision could become possible.
They trace Guardant’s journey from liquid biopsy to early cancer detection, the difficult decisions that shaped the company along the way, and why diagnostics is such a uniquely hard business to build.
Helmy also breaks down how AI is accelerating Guardant’s ability to analyze its data and opening the door to new applications far beyond cancer.
The future of blood testing could go far beyond cancer.
In diagnostics, building the technology is only one part of the job.
Early cancer detection only works at scale if people can actually access it.
Minus One is series about the winding journeys the world’s most interesting people take to becoming great—and what they do when figuring out a question we all face: What’s Next? Because before you launch at Zero, you have to figure out what to launch at Minus One. Hosted by South Park Commons Partners.
Interested in SPC? Apply to join us here.